Cover Image
市場調查報告書

全球海洋來源藥物市場預測 (2017∼2027年):各藥物 (酚、類固醇、以太、肽) 、各來源 (藻類、無脊椎動物、微生物) 、各用途、各地區預測

World Marine Derived Drugs Market Forecast 2017-2027: Prospects by Drug Type (Phenol, Steroid, Ether, Peptide), Source (Algae, Invertebrate, Microorganism), Application, and Geography

出版商 Visiongain Ltd 商品編碼 577296
出版日期 內容資訊 英文 172 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球海洋來源藥物市場預測 (2017∼2027年):各藥物 (酚、類固醇、以太、肽) 、各來源 (藻類、無脊椎動物、微生物) 、各用途、各地區預測 World Marine Derived Drugs Market Forecast 2017-2027: Prospects by Drug Type (Phenol, Steroid, Ether, Peptide), Source (Algae, Invertebrate, Microorganism), Application, and Geography
出版日期: 2017年09月25日 內容資訊: 英文 172 Pages
簡介

全球海洋原來藥物市場預計2017年超越93億美元。該市場預計至2027年收益大幅擴大。

本報告提供全球海洋來源藥物市場相關調查,今後的收益預測,各藥物、各來源、各用途、各地區的趨勢,及加入此市場的主要企業的簡介等彙整。

第1章 本報告概要

第2章 海洋來源藥物市場簡介

第3章 市場預測

  • 各類型
  • 各來源
  • 各用途

第4章 各類型市場預測

  • 概要
  • 類固醇
  • 以太
  • 其他

第5章 各來源市場

  • 概要
  • 藻類
  • 無脊椎動物
  • 微生物

第6章 各用途市場

  • 抗菌劑
  • 抗癌藥物
  • 心血管藥
  • 抗病毒藥物
  • 抗發炎藥

第7章 主要國家市場

  • 各地區明細
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 其他

第8章 定性分析

  • 波特五力分析
  • 促進因素與阻礙因素

第9章 主要企業

  • Abbott Laboratories Inc.
  • Abbvie Inc.
  • Pharma Marine AS
  • 武田藥品工業株式會社
  • Aker BioMarine AS
  • Marine Polymer Technologies, Inc.
  • Sea Run Holdings, Inc.
  • Aphios Corporation
  • Sanofi S.A. (Sanofi Genzyme)
  • 其他

第10章 結論

目錄
Product Code: PHA0242

Marine Derived Drugs - our new study reveals trends, R&D progress, and predicted revenues

Where is the Marine Derived Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead

Our 172-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Marine Derived Drugs market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level.

Global Marine-Derived Drugs Market by Type

  • Steroid
  • Ether
  • Peptide
  • Other

Global Marine-Derived Drugs Market by Source

  • Algae
  • Invertebrates
  • Microorganisms

Global Marine-Derived Drugs Market by Application

  • Anti-microbial
  • Anti-tumour
  • Anti-cardiovascular
  • Anti-viral
  • Anti-inflammatory
  • Other

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:

  • North America:
  • US
  • Canada
  • Mexico
  • South America:
  • Brazil
  • Argentina
  • Paraguay
  • Bolivia
  • Rest of South America

image1

  • Europe:
  • Germany
  • The UK
  • Italy
  • Spain
  • France
  • Rest of Europe
  • Asia-Pacific:
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • Rest of Asia-Pacific
  • Rest of the World:
  • Middle East
  • Africa
  • Other Countries

The report also includes profiles and for some of the leading companies in the Marine Derived Drugs market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Australia in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth

Overall world revenue for Marine Derived Drugs will surpass $9.3bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Marine Derived Drugs Market report helps you

In summary, our 172-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 7 regional and 17 key national markets - See forecasts for the marine-derived drugs market in North America, South America, Europe, Asia-Pacific, the Middle East, Africa and Other Countries. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Bolivia, Paraguay, Germany, France, the UK, Italy, Spain, China, India, Japan, Australia and Thailand
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Marine Derived Drugs market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Marine Derived Drugs market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Marine Derived Drugs Overview
  • 1.2 Research Methodology
    • 1.2.1 Primary Research
    • 1.2.2 Secondary Research
    • 1.2.3 Market Evaluation & Forecasting Methodology
  • 1.3 Global Marine-Derived Drugs Market Segmentation
  • 1.4 Overview of Findings
  • 1.5 Why You Should Read This Report
  • 1.6 How This Report Delivers
  • 1.7 Key Questions Answered by This Analytical Report
  • 1.8 Frequently Asked Questions (FAQ)
  • 1.9 Who is This Report For?
  • 1.10 Associated Visiongain Reports
  • 1.11 About Visiongain

2. Introduction to the Marine-Derived Drugs Market

3. Global Marine-Derived Drugs Market Forecast to 2027

  • 3.1 Marine-Derived Drugs Market by Type
  • 3.2 Marine-Derived Drugs Market by Source
  • 3.3 Marine-Derived Drugs Market by Application

4. Marine-Derived Drugs Market by Type: Market Forecast to 2027

  • 4.1 Overview
  • 4.2 Marine-Derived Phenol Drugs: Market Forecast to 2027
  • 4.3 Marine-Derived Steroid Drugs: Market Forecast to 2027
  • 4.4 Marine-Derived Ether Drugs: Market Forecast to 2027
  • 4.5 Marine-Derived Peptide Drugs: Market Forecast to 2027
  • 4.6 Other Marine-Derived Drugs: Market Forecast to 2027

5. Marine-Derived Drugs Market by Source: Market Forecast, 2017-2027

  • 5.1 Overview
  • 5.2 Algae-Derived Drugs Market: Market Forecast, 2017-2027
  • 5.3 Invertebrate-Derived Drugs Market: Market Forecast, 2017-2027
  • 5.4 Marine Microorganism-Derived Drugs Market: Market Forecast, 2017-2027

6. Marine-Derived Drugs Market by Application: Market Forecast, 2017-2027

  • 6.1 Marine-Derived Anti-Microbial Drugs: Market Forecast to 2027
  • 6.2 Marine-Derived Anti-Tumour Drugs: Market Forecast to 2027
  • 6.3 Marine-Derived Cardiovascular Drugs: Market Forecast to 2027
  • 6.4 Marine-Derived Anti-Viral Drugs: Market Forecast to 2027
  • 6.5 Marine-Derived Anti-Inflammatory Drugs: Market Forecast to 2027

7. Leading National Markets, 2017-2027

  • 7.1 Geographical Breakdown of the Global Marine-Derived Drugs Market
  • 7.2 North America Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.2.1 USA Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.2.2 Canada Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.2.3 Mexico Marine-Derived Drugs Market Forecast, 2017-2027
  • 7.3 South America Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.3.1 Brazil Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.3.2 Argentina Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.3.3 Paraguay Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.3.4 Bolivia Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.3.5 Rest of South America Marine-Derived Drugs Market Forecast, 2017-2027
  • 7.4 European Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.4.1 Germany Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.4.2 France Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.4.3 UK Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.4.4 Spain Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.4.5 Italy Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.4.6 Rest of Europe Marine-Derived Drugs Market Forecast, 2017-2027
  • 7.5 Asia-Pacific Marine-Derived Drugs Market Forecast, 2016-2027
    • 7.5.1 China Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.5.2 Japan Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.5.3 India Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.5.4 Australia Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.5.5 Thailand Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.5.6 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast, 2017-2027
  • 7.6 Rest of World Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.6.1 Middle East Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.6.2 Africa Marine-Derived Drugs Market Forecast, 2017-2027
    • 7.6.3 Other Countries Marine-Derived Drugs Market Forecast, 2017-2027

8. Marine-Derived Drugs Market, Qualitative Analysis, 2017-2027

  • 8.1 Porter's Five Forces Analysis of the Marine-Derived Drugs Market 2017-2027
    • 8.1.1 Bargaining Power of Buyers (High)
    • 8.1.2 Bargaining Power of Suppliers (Medium)
    • 8.1.3 Threat of New Entrants (Low)
    • 8.1.4 Threat of Substitute Products (Low)
    • 8.1.5 Intensity of Competitive Rivalry (High)
  • 8.2 Drivers & Restrains
    • 8.2.1 Rising Incidence and Prevalence of Various Cancer Types
    • 8.2.2 Increasing Investment from Government, Public and Private Sector
    • 8.2.3 Increasing Clinical Trials
    • 8.2.4 Increasing Popularity of Marine Derived Drugs
    • 8.2.5 Strong Growth in Emerging Markets
    • 8.2.6 New Healthcare Technologies May Enable Marine Derived Drugs Approvals
    • 8.2.7 Large pool of geriatric population and related rise in chronic diseases

9. Leading Companies in Marine-Derived Drugs Market

  • 9.1 Abbott Laboratories Inc.
    • 9.1.1 Abbott Laboratories Inc.: Company Overview
    • 9.1.2 Abbott Laboratories Inc.: Product Portfolio
  • 9.2 GlaxoSmithKline PLC
    • 9.2.1 GlaxoSmithKline PLC: Company Overview
    • 9.2.2 GlaxoSmithKline PLC: Product Portfolio
  • 9.3 Abbvie Inc.
    • 9.3.1 Abbvie Inc.: Company Overview
    • 9.3.2 Abbvie Inc.: Product Portfolio
  • 9.4 Pharma Marine AS
    • 9.4.1 Pharma Marine: Company Overview
    • 9.4.2 Pharma Marine: Product Portfolio
  • 9.5 Takeda Pharmaceutical Company Ltd. (Takeda Oncology's Millennium)
    • 9.5.1 Takeda Pharmaceutical Company Ltd.: Company Overview
    • 9.5.2 Takeda Pharmaceutical Company Ltd.: Product Portfolio
    • 9.5.3 Takeda Pharmaceutical Company Ltd.: Recent Developments
  • 9.6 Aker BioMarine AS
    • 9.6.1 Aker BioMarine AS: Company Overview
    • 9.6.2 Aker BioMarine AS: Recent Developments
  • 9.7 Marine Polymer Technologies, Inc.
    • 9.7.1 Marine Polymer Technologies, Inc.: Company Overview
  • 9.8 Sea Run Holdings, Inc.
    • 9.8.1 Sea Run Holdings, Inc.: Company Overview
    • 9.8.2 Sea Run Holdings, Inc.: Product Portfolio
  • 9.9 Aphios Corporation
    • 9.9.1 Aphios Corporation: Company Overview
    • 9.9.2 Aphios Corporation: Product Portfolio
  • 9.10 Sanofi S.A. (Sanofi Genzyme)
    • 9.10.1 Sanofi S.A.: Company Overview
    • 9.10.2 Sanofi S.A.: Product Portfolio
  • 9.11 Other Companies of Interest in the Marine Derived Drugs Market

10. Conclusions

  • 10.1 Current Leading Segments
  • 10.2 Leading Regional Markets
  • 10.3 Emerging Markets
  • 10.4 The Future of the Market?

11. Glossary

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 3.1 Marine-Derived Drugs Market, by Type, ($m), 2017-2027
  • Figure 3.2 Marine-Derived Drugs Market, by Source, ($m), 2017-2027
  • Figure 3.3 Marine-Derived Drugs Market, by Application, ($m), 2017-2027
  • Figure 4.1 Marine-Derived Drugs Market, by Type (%), 2016
  • Figure 4.2 Marine-Derived Drugs Market, by Type, Forecast ($m) 2017-2027
  • Figure 4.3 Global Marine-Derived Phenol Drugs Market Forecast, by Geography, ($m) 2017-2027
  • Figure 4.4 Global Marine-Derived Steroid Drugs Drugs Market Forecast, by Geography, ($m) 2017-2027
  • Figure 4.5 Global Marine-Derived Ether Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
  • Figure 4.6 Global Marine-Derived Peptide Drugs Market Forecast, by Geography, ($m) 2017-2027
  • Figure 4.7 Global Other Marine-Derived Drugs Market Forecast, by Geography, ($m) 2017-2027
  • Figure 5.1 Marine-Derived Drugs Market, by Source, ($m) 2017-2027
  • Figure 5.2 Marine-Derived Drugs Market, by Source, Market Share (%), 2016
  • Figure 5.3 Algae-Derived Drugs Market Forecast, by Geography ($m) 2017-2027
  • Figure 5.4 Invertebrate-Derived Drugs Market Forecast, by Geography($m) 2017-2027
  • Figure 5.5 Marine Microorganism-Derived Drugs Market, by Geography($m) 2017-2027
  • Figure 6.1 Marine-Derived Drugs Market Forecast, by Application, ($million) 2017-2027
  • Figure 6.2 Marine-Derived Drugs Market, by Application, Market Share (%), 2016
  • Figure 6.3 Marine-Derived Drugs Market Forecast for Anti-microbial, by Geography, ($m) 2017-2027
  • Figure 6.4 Marine-Derived Drugs Market Forecast for Anti-tumour, by Geography, ($m) 2017-2027
  • Figure 6.5 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, by Geography, ($m) 2017-2027
  • Figure 6.6 Marine-Derived Drugs Market Forecast for Anti-viral, by Geography, ($m) 2017-2027
  • Figure 6.7 Marine-Derived Drugs Market Forecast for Anti-Inflammatory, by Geography, ($m) 2017-2027
  • Figure 6.8 Marine-Derived Drugs Market Forecast for Other Indications, by Geography ($m) 2017-2027
  • Figure 7.1 Global Marine-Derived Drugs Market Forecast, by Geography($m) 2017-2027
  • Figure 7.2 Global Marine-Derived Drugs Market Forecast, by Geography, Market Share (%), 2016
  • Figure 7.3 North America Marine-Derived Drugs Market Forecast, by Country, ($m), 2017-2027
  • Figure 7.4 North America Marine-Derived Drugs Market Forecast, by Geography, Market Share (%), 2016
  • Figure 7.5 USA Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.6 Canada Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.7 Mexico Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.8 South America Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027
  • Figure 7.9 South America Marine-Derived Drugs Market, by Country, Market Share (%), 2016
  • Figure 7.10 Brazil Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.11 Argentina Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.12 Paraguay Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.13 Bolivia Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.14 Rest of South America Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.15 Europe Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027
  • Figure 7.16 Europe Marine-Derived Drugs Market, by Country, Market Share (%), 2016
  • Figure 7.17 Germany Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.18 France Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.19 UK Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.20 Spain Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.21 Italy Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.22 Rest of Europe Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.23 Asia-Pacific Marine-Derived Drugs Market Forecast, by Country($million) 2017-2027
  • Figure 7.24 Asia-Pacific Marine-Derived Drugs Market, Market Share (%), 2016
  • Figure 7.25 China Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.26 Japan Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.27 India Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.28 Australia Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.29 Thailand Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.30 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.31 RoW Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027
  • Figure 7.32 Rest of World Marine-Derived Drugs Market, by Country, Market Share (%), 2016
  • Figure 7.33 Middle East Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.34 Africa Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 7.35 Other Countries Marine-Derived Drugs Market Forecast ($m) 2017-2027
  • Figure 8.1 Porter's Five Forces Analysis of the Marine-Derived Drugs Market
  • Figure 9.1 Abbott Laboratories Inc., Revenue, ($million), 2012-2016
  • Figure 9.2 Abbott Laboratories Inc., Geographic Presence Share (%), 2016
  • Figure 9.3 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016
  • Figure 9.4 GlaxoSmithKline PLC, Product Segments Share (%), 2016
  • Figure 9.5 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016
  • Figure 9.6 Abbvie Inc., Revenue, ($million), 2012-2016
  • Figure 9.7 Abbvie Inc.,Product Segments Share (%), 2016
  • Figure 9.8 Abbvie Inc., Geographical Presence Share (%), 2016
  • Figure 9.9 Takeda Pharmaceutical Company Ltd., Revenue, ($million), 2012-2016
  • Figure 9.10 Aker BioMarine AS, Revenue, ($million), 2012-2016
  • Figure 9.11 Aker BioMarine AS., Geographical Presence Share (%), 2016
  • Figure 9.12 Sanofi S.A., Revenue, ($million), 2012-2016
  • Figure 9.13 Sanofi S.A., Product Segments Share (%), 2016
  • Figure 9.14 Sanofi S.A., Geographical Presence Share (%), 2016
  • Figure 10.1 World Marine-Derived Drugs, by Type, ($million), 2017-2027
  • Figure 10.2 World Marine-Derived Drugs, by Sources, ($million), 2017-2027
  • Figure 10.3 World Marine-Derived Drugs, by End-User, ($million), 2017-2027
  • Figure 10.4 World Marine-Derived Drugs, by Geography, ($million), 2017-2027

List of Tables

  • Table 3.1. Marine-Derived Drugs Market Forecast ($m, AGR%) 2017-2027
  • Table 4.1. Marine-Derived Drugs Market Forecast, by Type ($m, AGR%) 2017-2027
  • Table 4.2 Global Marine-Derived Phenol Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 4.3 Marine-Derived Phenol Drugs Market Forecast, by Geography, ($m, AGR%) 2017-2027
  • Table 4.4 Global Marine-Derived Steroid Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 4.5 Global Marine-Derived Steroid Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
  • Table 4.6 Global Marine-Derived Ether Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 4.7 Global Marine-Derived Ether Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
  • Table 4.8 Global Marine-Derived Peptide Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 4.9 Global Marine-Derived Peptide Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
  • Table 4.10 Global Other Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 4.11 Global Other Marine-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
  • Table 5.1 Marine-Derived Drugs Market, by Source ($m, AGR%) 2017-2027
  • Table 5.2 Algae-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 5.3 Algae-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
  • Table 5.4 Invertebrate-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 5.5 Invertebrate-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027
  • Table 5.6 Marine Microorganism-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 5.7 Marine Microorganism-Derived Drugs Market, by Geography ($m, AGR%) 2017-2027
  • Table 6.1 Marine-Derived Drugs Market, by Application($m, AGR%) 2017-2027
  • Table 6.2 Marine-Derived Drugs Market Forecast for Anti-Microbial Applications ($m, AGR%) 2017-2027
  • Table 6.3 Marine-Derived Drugs Market Forecast for Anti-microbial, by Geography ($m, AGR%), 2017-2027
  • Table 6.4 Marine-Derived Drugs Market Forecast for Anti-Microbial ($m, AGR%) 2017-2027
  • Table 6.5 Marine-Derived Drugs Market Forecast for Anti-tumour, by Geography ($m, AGR%) 2017-2027
  • Table 6.6 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, ($m, AGR%) 2017-2027,
  • Table 6.7 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, by Geography ($m, AGR%) 2017-2027
  • Table 6.8 Marine-Derived Drugs Market Forecast for Anti-viral ($m, AGR%) 2017-2027
  • Table 6.9 Marine-Derived Drugs Market Forecast for Anti-viral, by Geography ($m, AGR%) 2017-2027
  • Table 6.10 Marine-Derived Drugs Market Forecast for Anti- inflammatory ($m, AGR%) 2017-2027
  • Table 6.11 Marine-Derived Drugs Market Forecast for Anti-Inflammatory, by Geography ($m. AGR%) 2017-2027
  • Table 6.12 Marine-Derived Drugs Market for Other Indications, ($m, AGR%) 2017-2027
  • Table 6.13 Marine-Derived Drugs Market Forecast for Other Indications, by Geography ($m, AGR%) 2017-2027
  • Table 7.1 Marine-Derived Drugs Market Forecast by Geography ($m, AGR%) 2017-2027
  • Table 7.2 North America Marine-Derived Drugs Market Forecast, by Country, ($m, AGR%), 2017-2027
  • Table 7.3 USA Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.4 Canada Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.5 Mexico Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.6 South America Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
  • Table 7.7 Brazil Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.8 Argentina Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.9 Paraguay Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.10 Bolivia Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.11 Rest of South America Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.12 European Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
  • Table 7.13 Germany Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.14 France Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.15 UK Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.16 Spain Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.17 Italy Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.18 Rest of European Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.19 Asia-Pacific Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
  • Table 7.20 China Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.21 Japan Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.22 India Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.23 Australia Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.24 Thailand Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.25 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.26 Rest of World Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027
  • Table 7.27 Middle East Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.28 Africa Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 7.29 Other Countries Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027
  • Table 8.2 Worldwide Estimated Incidence and Prevalence of all Cancer Types, (2012)
  • Table 9.1 Abbott Laboratories Inc.: Company Overview
  • Table 9.2 Abbott Laboratories Inc.: Product Portfolio
  • Table 9.3 GlaxoSmithKline PLC: Company Overview
  • Table 9.4 GlaxoSmithKline PLC: Product Portfolio
  • Table 9.5 Abbvie Inc.: Company Overview
  • Table 9.6 Abbvie Inc.: Product Portfolio
  • Table 9.7 Pharma Marine: Company Overview
  • Table 9.8 Pharma Marine: Product Portfolio
  • Table 9.9 Takeda Pharmaceutical Company Ltd.: Company Overview
  • Table 9.10 Takeda Pharmaceutical Company Ltd.: Product Portfolio
  • Table 9.11 Takeda Pharmaceutical Company Ltd.: Recent Developments
  • Table 9.12 Aker BioMarine AS: Company Overview
  • Table 9.13 Aker BioMarine AS: Recent Developments
  • Table 9.14 Marine Polymer Technologies, Inc.: Company Overview
  • Table 9.15 Sea Run Holdings, Inc.: Company Overview
  • Table 9.16 Sea Run Holdings, Inc.: Product Portfolio
  • Table 9.17 Aphios Corporation: Company Overview
  • Table 9.18 Aphios Corporation: Product Portfolio
  • Table 9.19 Sanofi S.A.: Company Overview
  • Table 9.20 Sanofi S.A.: Product Portfolio
  • Table 9.21 Other Companies of Interest in the Marine Derived Drugs Market
  • Table 9.21 Other Companies of Interest in the Marine Derived Drugs Market (continued)

Companies Listed

  • Abbott Laboratories
  • AbbVie, Inc.
  • Alkermes Plc
  • Amarin Corp. Plc
  • Amgen, Inc.
  • Amnis Corporation
  • Aphios Corporation
  • Array BioPharma, Inc.
  • Associates Of Cape Cod Inc.
  • Astex Pharmaceuticals Inc.
  • AstraZeneca Plc
  • ASYMPTOTE LTD
  • Bayer AG
  • Bayer Corporation
  • Bayer HealthCare AG
  • Bayer Schering Pharma Aktiengesellschaft
  • BioMarin Pharmaceutical, Inc.
  • Biotest AG
  • Bristol-Myers Squibb Co.
  • Cardax, Inc.
  • Ceapro, Inc.
  • Celgene Corp.
  • Centene Corp.
  • Cephalon, Inc.
  • Chugai Pharmaceutical Co., Ltd.
  • CK Life Sciences International (Holdings), Inc.
  • CTI BioPharma Corp.
  • Deroyal Industries Inc.
  • Domain Therapeutics SA
  • Emd Millipore Corporation
  • Emd Serono Inc.
  • Endo International Plc
  • Evotec AG
  • GE HEALTHCARE LTD
  • GlaxoSmithKline Plc
  • Henry Schein, Inc.
  • International Medical Corps
  • Janssen Biotech, Inc.
  • JHL Biotech, Inc.
  • Johnson & Johnson
  • Laboratoire Theramex
  • Lombard Medical, Inc.
  • Lonza Group AG
  • Marine Polymer Technology
  • Medtronic Plc
  • Merck KGaA
  • MorphoSys AG
  • Myrexis, Inc.
  • NBTY, Inc.
  • Neptune Technologies & Bioresources, Inc.
  • Nexvet Biopharma PLC
  • Nordion Inc
  • Novartis AG
  • Opexa Therapeutics, Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Panacos Pharmaceuticals, Inc.
  • PELICAN HEALTHCARE LTD
  • Pfizer Inc.
  • Pharma Mar SA
  • Polymer Technology Systems Inc.
  • Premier Healthcare Alliance L.P.
  • Progyny Inc.
  • Quanterix Corp.
  • Samsung BioLogics Co., Ltd.
  • Sangers (Northern Ireland) Limited
  • Sanofi
  • Sea Run Holdings
  • Spectrum Pharmaceuticals, Inc.
  • T G EAKIN LTD
  • Taiho Pharmaceutical Co. Ltd.
  • Takeda Pharmaceutical Co., Ltd.
  • UnitedHealth Group, Inc.
  • Verastem, Inc.
  • Vertex Pharmaceuticals, Inc.
  • VWR International, LLC
  • Windtree Therapeutics, Inc.
  • Zogenix, Inc.

List of Organizations

  • Australian Institute Of Health And Welfare
  • European Medicines Agency
  • Food Drug and Administration
  • Health Canada
  • Ministry of Health, Labor and Welfare
  • National Cancer Institute
  • The American Society Of Clinical Oncology Inc
  • The Feinstein Institute For Medical Research
  • United States Department Of Health & Human Services
  • World Health Organization
Back to Top